Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -19.577% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
[a] O=C1c2ccccc2S(=O)(=O)N1Cc1nc2ccccc2s1
[b] CC(C)[C@H](NC(=O)NC1CCN(Cc2ccccc2)CC1)C(=O)O
[c] CCn1c(CCNC(=O)c2ccc(Cl)cc2)nnc1SCC(=O)NC1CCCC1
[d] Cc1c(N2C(=O)/C(=C3/C(=O)N(C)c4ccccc43)SC2=S)c(=O)n(-c2ccccc2)n1C
[e] Cc1ccn2c(CNCCn3cccn3)c(C(=O)N3CCCCCC3)nc2c1
Answer: c. CCn1c(CCNC(=O)c2ccc(Cl)cc2)nnc1SCC(=O)NC1CCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(CCNC(=O)c2ccc(Cl)cc2)nnc1SCC(=O)NC1CCCC1
CCn1c(CCNC(=O)c2ccc(Cl)cc2)nnc1SCC(=O)NC1CCCC1
4-chloro-N-[2-[5-[2-(cyclopentylamino)-2-oxoethyl]sulfanyl-4-ethyl-1,2,4-triazol-3-yl]ethyl]benzamide